Shreeram Agharkar, Director at RELMADA THERAPEUTICS, INC. (RLMD), bought 1,100 shares at $3.45 ($4K) on 2015-12-16, disclosed to the SEC on 2015-12-17.
Open-market purchase of $4k RLMD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.25 | 100 | $325 | 8.6% |
| 2 | $3.45 | 1,000 | $3K | 91.4% |
| Total | $3.43 avg | 1,100 | $4K | 100% |